health insurance

Share

Vitality Re IX health ILS from Aetna priced below guidance

The $200 million Vitality Re IX Ltd. (Series 2018-1) health insurance-linked securities (ILS) transaction from Aetna has now been priced and both tranches of notes have had their coupons fixed at levels below the bottom-end of the initial price guidance ranges.The Vitality Re series of health insurance ILS transactions are read the full article →

Vitality Re IX pricing delayed on health insurer fee uncertainty

Pricing for the in-the-market $200 million Vitality Re IX Ltd. (Series 2018-1) health insurance-linked securities (ILS) issuance has been delayed due to uncertainty over the future of health insurer fees, because the U.S. government has been considering the fees as part of government shutdown related budgetary debates.The so-called anti-shutdown bill, read the full article →